Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2024
4 years of board service in total across 2 boards, counting each seat separately. Longest: Dermata Therapeutics Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cytokinetics Incorporated May 27, 202679.2%
-
Dermata Therapeutics Inc. May 7, 202498.7%
-
Cytokinetics Incorporated May 10, 202391.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 16, 2026 | Cytokinetics Incorporated | Grant or award | +97 | $63.92 | $6,200 |
| Jul 15, 2026 | Cytokinetics Incorporated | Grant or award | +75 | $82.62 | $6,197 |
| May 27, 2026 | Cytokinetics Incorporated | Grant or award | +2,851 | — | — |
| May 5, 2026 | Cytokinetics Incorporated | Option exercise | +4,032 | $12.40 | $49,997 |
| May 5, 2026 | Cytokinetics Incorporated | Open-market sale | −4,032 | $75.00 | $302,400 |
| Apr 15, 2026 | Cytokinetics Incorporated | Grant or award | +95 | $65.37 | $6,210 |
| Jan 15, 2026 | Cytokinetics Incorporated | Grant or award | +98 | $63.44 | $6,217 |
| Dec 22, 2025 | Cytokinetics Incorporated | Option exercise | +20,000 | $7.61 | $152,200 |
| Dec 22, 2025 | Cytokinetics Incorporated | Open-market sale | −20,000 | $66.14 | $1,322,800 |
| Oct 27, 2025 | Cytokinetics Incorporated | Option exercise | +4,375 | $10.00 | $43,750 |
| Oct 27, 2025 | Cytokinetics Incorporated | Open-market sale | −4,375 | $58.68 | $256,725 |
| Oct 15, 2025 | Cytokinetics Incorporated | Grant or award | +99 | $62.80 | $6,217 |
Questions about Wendell Wierenga
What boards is Wendell Wierenga on?
Wendell Wierenga sits on the boards of Cytokinetics Incorporated and Dermata Therapeutics Inc.
How long has Wendell Wierenga served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.